Atlant Stability vs UBS Lux Equity Fund Biotech USD
1. Atlant Stability
-
Security
Atlant Stability
-
Fee
0.50%
-
ISIN
SE0002623553
-
Holdings
20
2. UBS Lux Equity Fund Biotech USD
Fund Holdings
We have information about 1 holdings in Atlant Stability, where the largest holding is (8.89), followed by (3.16) and (3.03). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).
All Holdings
Here we compare the holdings in Atlant Stability and UBS Lux Equity Fund Biotech USD.
Atlant Stability |
UBS Lux Equity Fund Biotech USD |
1. 8.89 % |
1. Regeneron Pharmaceuticals Inc 10.04 % |
2. 3.16 % |
2. Vertex Pharmaceuticals Inc 9.35 % |
3. 3.03 % |
3. Moderna Inc 9.21 % |
4. 2.86 % |
4. Alnylam Pharmaceuticals Inc 6.96 % |
5. 2.42 % |
5. AbbVie Inc  5.53 % |
6. 2.15 % |
6. Gilead Sciences Inc  4.66 % |
7. 2.08 % |
7. Amgen Inc 4.3 % |
8. 1.98 % |
8. BioNTech SE 4.13 % |
9. 1.87 % |
9. Karuna Therapeutics Inc 3.75 % |
10. 1.76 % |
10. Royalty Pharma Plc 3.37 % |
11. 1.65 % |
- |
12. 1.65 % |
- |
13. 1.54 % |
- |
14. 1.49 % |
- |
15. 1.47 % |
- |
16. 1.46 % |
- |
17. 1.44 % |
- |
18. 1.4 % |
- |
19. 1.35 % |
- |
20. 1.31 % |
- |
The list of fund holdings was last updated on June 5, 2025.